Chemoinformaics analysis of nuatigenin 3-beta-D-glucopyranoside
| Molecular Weight | 592.77 | nRot | 4 |
| Heavy Atom Molecular Weight | 540.354 | nRig | 35 |
| Exact Molecular Weight | 592.361 | nRing | 7 |
| Solubility: LogS | -3.608 | nHRing | 3 |
| Solubility: LogP | 2.541 | No. of Aliphatic Rings | 7 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 94 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 33 | No. of Saturated Rings | 6 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
| nHA | 9 | APOL | 97.0012 |
| nHD | 5 | BPOL | 59.1108 |
| QED | 0.312 |
| Synth | 5.913 |
| Natural Product Likeliness | 3.143 |
| NR-PPAR-gamma | 0.031 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.007 |
| HIA | 0.368 |
| CACO-2 | -4.916 |
| MDCK | 0.0000599 |
| BBB | 0.047 |
| PPB | 0.930556 |
| VDSS | 0.818 |
| FU | 0.0673638 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.504 |
| CYP2c19-inh | 0.002 |
| CYP2c19-sub | 0.872 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.068 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.22 |
| CYP3a4-inh | 0.136 |
| CYP3a4-sub | 0.18 |
| CL | 9.851 |
| T12 | 0.073 |
| hERG | 0.013 |
| Ames | 0.09 |
| ROA | 0.944 |
| SkinSen | 0.012 |
| Carcinogencity | 0.361 |
| EI | 0.004 |
| Respiratory | 0.283 |
| NR-Aromatase | 0.738 |
| Antiviral | Yes |
| Prediction | 0.606494 |